These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23927625)

  • 21. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?
    Lima FM; Oliveira P; Mortara RA; Silveira JF; Bahia D
    N Biotechnol; 2010 Dec; 27(6):837-43. PubMed ID: 20172059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morita-Baylis-Hillman adducts: biological activities and potentialities to the discovery of new cheaper drugs.
    Lima-Junior CG; Vasconcellos ML
    Bioorg Med Chem; 2012 Jul; 20(13):3954-71. PubMed ID: 22632793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimalarial aminothiazoles and aminopyridines from phenotypic whole-cell screening of a SoftFocus(®) library.
    Paquet T; Gordon R; Waterson D; Witty MJ; Chibale K
    Future Med Chem; 2012 Dec; 4(18):2265-77. PubMed ID: 23234550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease.
    Rassi A; Dias JC; Marin-Neto JA; Rassi A
    Heart; 2009 Apr; 95(7):524-34. PubMed ID: 19131444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of Latin American plants for antiparasitic activities against malaria, Chagas disease, and leishmaniasis.
    Calderón AI; Romero LI; Ortega-Barría E; Solís PN; Zacchino S; Gimenez A; Pinzón R; Cáceres A; Tamayo G; Guerra C; Espinosa A; Correa M; Gupta MP
    Pharm Biol; 2010 May; 48(5):545-53. PubMed ID: 20645798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicinal fungi: a source of antiparasitic secondary metabolites.
    Lenzi J; Costa TM; Alberton MD; Goulart JAG; Tavares LBB
    Appl Microbiol Biotechnol; 2018 Jul; 102(14):5791-5810. PubMed ID: 29749562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmodium kinases as targets for new-generation antimalarials.
    Lucet IS; Tobin A; Drewry D; Wilks AF; Doerig C
    Future Med Chem; 2012 Dec; 4(18):2295-310. PubMed ID: 23234552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidosqualene cyclase from Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii and Arabidopsis thaliana expressed in yeast: a model for the development of novel antiparasitic agents.
    Balliano G; Dehmlow H; Oliaro-Bosso S; Scaldaferri M; Taramino S; Viola F; Caron G; Aebi J; Ackermann J
    Bioorg Med Chem Lett; 2009 Feb; 19(3):718-23. PubMed ID: 19119009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opportunities and challenges in antiparasitic drug discovery.
    Pink R; Hudson A; Mouriès MA; Bendig M
    Nat Rev Drug Discov; 2005 Sep; 4(9):727-40. PubMed ID: 16138106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Infectiology and tropical medicine 2007].
    Löbermann M; Reisinger EC
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1399-403. PubMed ID: 17570089
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spread and evolution of Plasmodium falciparum drug resistance.
    Mita T; Tanabe K; Kita K
    Parasitol Int; 2009 Sep; 58(3):201-9. PubMed ID: 19393762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antiparasitic and antifungal evaluation of 2'-arylsubstituted-1H,1'H-[2,5']bisbenzimidazolyl-5-carboxamidines.
    Alp M; Göker H; Brun R; Yildiz S
    Eur J Med Chem; 2009 May; 44(5):2002-8. PubMed ID: 19010569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chagas Disease Drug Discovery in Latin America-A Mini Review of Antiparasitic Agents Explored Between 2010 and 2021.
    de Oliveira RG; Cruz LR; Mollo MC; Dias LC; Kratz JM
    Front Chem; 2021; 9():771143. PubMed ID: 34778217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic screens targeting neurodegenerative diseases.
    Zhang M; Luo G; Zhou Y; Wang S; Zhong Z
    J Biomol Screen; 2014 Jan; 19(1):1-16. PubMed ID: 23958650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New strategies and paradigm for drug target discovery: a special focus on infectious diseases tuberculosis, malaria, leishmaniasis, trypanosomiasis and gastritis.
    Neelapu NR; Srimath-Tirumala-Peddinti RC; Nammi D; Pasupuleti AC
    Infect Disord Drug Targets; 2013 Oct; 13(5):352-64. PubMed ID: 24712675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New trends in chemotherapy on human and animal blood parasites.
    Schrével J; Millerioux V; Sinou V; Frappier F; Santus R; Grellier P
    Parasitol Res; 1996; 82(3):283-4. PubMed ID: 8801568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From Medicinal Chemistry to Human Health: Current Approaches to Drug Discovery for Cancer and Neglected Tropical Diseases.
    Ferreira LG; Oliva G; Andricopulo AD
    An Acad Bras Cienc; 2018; 90(1 Suppl 1):645-661. PubMed ID: 29451603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating novel potential drug targets of Plasmodium falciparum by analysing the metabolic network of knock-out strains in silico.
    Fatumo S; Plaimas K; Mallm JP; Schramm G; Adebiyi E; Oswald M; Eils R; König R
    Infect Genet Evol; 2009 May; 9(3):351-8. PubMed ID: 18313365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and preparation of sterol mimetics as potential antiparasitics.
    Gigante F; Kaiser M; Brun R; Gilbert IH
    Bioorg Med Chem; 2010 Oct; 18(20):7291-301. PubMed ID: 20846867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.